- 2 updates
The number of men with prostate cancer in the UK is rising every year, and it is predicted to become the most common cancer of all in the UK by 2030. Currently 10,000 men every year die of the disease, according to Prostate Cancer UK: more than one every hour.
Despite this prostate cancer receives "a fraction" of the research money that breast cancer receives.
The charity has launched a new campaign, the Sledgehammer Fund, which aims to generate cash to support its work to increase research spending into the disease, as well as improve the support men receive.
Research into the most common male cancer in the UK is "chronically underfunded" compared with its female equivalent, according to Prostate Cancer UK.
New figures show that although it is the fourth most common cancer overall, prostate cancer lies 20th in the league table of annual cancer research spending per case diagnosed.
The figures show that breast cancer - the most common female cancer, which has a similar death rate as prostate cancer - received more than double the annual research spend.
While breast cancer research received £853 per case diagnosed, prostate cancer research received £417.